Chemoinformaics analysis of 2,3,4-Trimethylbenzaldehyde
| Molecular Weight | 148.205 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 23 |
| Exact Molecular Weight | 148.089 | nRing | 1 |
| Solubility: LogS | -2.096 | nHRing | 0 |
| Solubility: LogP | 1.523 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 25.5035 |
| nHD | 0 | BPOL | 12.9065 |
| QED | 0.708 |
| Synth | 5.218 |
| Natural Product Likeliness | 2.751 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.817 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.826 |
| MDCK | 0.0000414 |
| BBB | 0.407 |
| PPB | 0.411452 |
| VDSS | 2.213 |
| FU | 0.71526 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.068 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.773 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.144 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.885 |
| CYP3a4-inh | 0.114 |
| CYP3a4-sub | 0.886 |
| CL | 14.668 |
| T12 | 0.173 |
| hERG | 0.096 |
| Ames | 0.016 |
| ROA | 0.09 |
| SkinSen | 0.417 |
| Carcinogencity | 0.154 |
| EI | 0.009 |
| Respiratory | 0.806 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.886562 |